Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.34 USD | +0.51% | +0.31% | +8.21% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.21% | 3.44B | |
+14.55% | 131B | |
-7.45% | 11.25B | |
-10.14% | 7.84B | |
+42.95% | 5.72B | |
-17.77% | 4.97B | |
-19.83% | 2.46B | |
-13.82% | 2.02B | |
-15.84% | 1.87B | |
-31.39% | 1.59B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Axonics Implant Approved in Australia to Treat Overactive Bladders